ALNYLAM PHARMACEUTICALS, INC. (ALNY) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.33 | +206.9% |
| 2024 | $-2.18 | +38.1% |
| 2023 | $-3.52 | +62.2% |
| 2022 | $-9.30 | -29.2% |
| 2021 | $-7.20 | +3.5% |
| 2020 | $-7.46 | +8.0% |
| 2019 | $-8.11 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $2.33 | +206.9% |
| 2024 | $-2.18 | +38.1% |
| 2023 | $-3.52 | +62.2% |
| 2022 | $-9.30 | -29.2% |
| 2021 | $-7.20 | +3.5% |
| 2020 | $-7.46 | +8.0% |
| 2019 | $-8.11 | — |